RetinaLyze System A/S
About RetinaLyze System A/S
RetinaLyze System A/S is a Denmark-based healthcare AI company specializing in artificial intelligence and telemedicine solutions for the optometry and healthcare industries. Their core offering is an eye-screening software that assists eye care professionals in the early detection of retinal pathologies by automatically analyzing fundus images and Optical Coherence Tomography (OCT) scans. The system delivers instant results, functioning as a clinical decision support system or a screening tool in conjunction with a telemedicine module.
The software is widely utilized in various settings, including hospitals, eye clinics, optical chains, and optometrists’ stores, and has performed over 7 million screenings. RetinaLyze aims to facilitate global access to eye examinations, thereby preventing the adverse effects of untreated retinal conditions by automating routine screening tasks, which enhances the affordability and accessibility of eye care services. The company is also actively involved in research and development to detect new diseases in retinal images, such as Alzheimer’s, using advanced AI algorithms.
For physicians, RetinaLyze provides a fast, intelligent, and effortless screening workflow, integrating with over 60 device and software partners. It offers explainable results with overlays and extracts measurements like cup/disc ratio and disc area. The system supports compliant and efficient operations, reducing manual workload for eye specialists and improving the quality of screening by enabling timely referrals.
Focus Areas
Business Intelligence
| Key Investors | INCUBA, Central Denmark Region, Jens Erik Mohr Thygesen, Lasse Nilsson Bundgaard |
| Partnerships | EyeVinci B.V. (Netherlands), Medicontur CZ s.r.o. (Czech Republic), FE-Group srl (Italy), Surveye s.r.o. (Slovakia), Medibrix, OCULUS spol. s r.o. (Czechia), Rockmed Vision (Benelux) |
| Technology | Cloud-based, automated AI analyzing fundus images and OCT scans, telemedicine module, integrations with 60+ device and software partners, 3D ONH morphology visualization, perimetry analysis |
What Physicians Need to Know
For physicians, RetinaLyze offers a powerful tool to enhance patient care and practice efficiency. Leverage its AI to achieve earlier and more accurate detection of Diabetic Retinopathy, AMD, and Glaucoma, even identifying subtle changes that might otherwise be missed. The rapid analysis (under a minute for most screenings) allows for increased patient throughput and frees up valuable time for complex cases. Utilize the integrated telemedicine feature for expert ophthalmologist consultations and validated referrals, which can significantly reduce false positives and build stronger referral relationships. The unique 3D ONH morphology visualization provides crucial structural and perfusion insights from standard 2D images, a valuable asset especially in clinics without immediate OCT access. Furthermore, the Glaucoma Index of Progression (GIP) enables precise tracking of disease progression over time, facilitating proactive management. The system's explainable AI results with visual overlays and comprehensive, redesigned PDF reports streamline documentation and communication with both colleagues and patients, ensuring consistent, high-quality care regardless of staff experience. By centralizing patient data and images, RetinaLyze simplifies longitudinal comparisons of retinal changes, supporting better long-term patient management.
RetinaLyze is a cloud-based web application compatible with the majority of commercially available fundus and OCT cameras. It can be accessed online via a web browser or seamlessly integrated into existing healthcare center software systems. The platform supports integration with PACS/EHR for efficient digital referrals, and the RetinaLyze OCT module is also available via API for custom integrations.
What the Web Says
RetinaLyze System A/S, known for its RetCAD and RetAlyze products, generally receives positive feedback for its innovative AI-powered retinal image analysis tools, particularly for ophthalmologists and optometrists. Users appreciate its efficiency in detecting and managing eye diseases. Employer reviews are less prevalent but suggest a positive work environment.
Overall: PositiveStrengths
- AI-powered analysis for efficient disease detection (e.g., AMD, DR)
- Enhances diagnostic accuracy for ophthalmologists and optometrists
- Streamlines workflow in eye care practices
- User-friendly interface for medical professionals
- Potential for early intervention and improved patient outcomes
- Positive impact on clinical decision-making
Limitations
- Limited public reviews on major platforms like G2, Capterra, Glassdoor
- Specific pricing information not readily available
- Potential learning curve for new users integrating into existing systems
- Reliance on internet connectivity for cloud-based features
- Specific technical support experiences are not widely documented
- No significant negative product or employer reviews found
Based on reviews from: RetinaLyze.com (product information), Healthcare IT news articles and industry reviews, Ophthalmology and optometry professional forums (limited mentions), LinkedIn (company information, employee profiles)
Last updated: 2026-08-12
Videos
News, demos, and interviews about RetinaLyze System A/S.
Videos load interactively. If none appear, search YouTube for RetinaLyze System A/S →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]